TY - JOUR
T1 - Genotyping the future
T2 - Scientists' expectations about race/ethnicity after BiDil
AU - Tutton, Richard
AU - Smart, Andrew
AU - Martin, Paul A.
AU - Ashcroft, Richard
AU - Ellison, George T.H.
PY - 2008/9
Y1 - 2008/9
N2 - The ongoing debate about the FDA approval of BiDil in 2005 demonstrates how the first racially/ethnically licensed drug is entangled in both Utopian and dystopian future visions about the continued saliency of race/ethnicity in science and medicine. Drawing on the sociology of expectations, this paper analyzes how scientists in the field of pharmacogenetics are constructing certain visions of the future with respect to the use of social categories of race/ethnicity and the impact of high-throughput genotyping technologies that promise to transform scientific practices.
AB - The ongoing debate about the FDA approval of BiDil in 2005 demonstrates how the first racially/ethnically licensed drug is entangled in both Utopian and dystopian future visions about the continued saliency of race/ethnicity in science and medicine. Drawing on the sociology of expectations, this paper analyzes how scientists in the field of pharmacogenetics are constructing certain visions of the future with respect to the use of social categories of race/ethnicity and the impact of high-throughput genotyping technologies that promise to transform scientific practices.
UR - http://www.scopus.com/inward/record.url?scp=50249170363&partnerID=8YFLogxK
U2 - 10.1111/j.1748-720X.2008.292.x
DO - 10.1111/j.1748-720X.2008.292.x
M3 - Article
C2 - 18840237
AN - SCOPUS:50249170363
SN - 1073-1105
VL - 36
SP - 464
EP - 470
JO - Journal of Law, Medicine and Ethics
JF - Journal of Law, Medicine and Ethics
IS - 3
ER -